VB10.NEO, AN INDIVIDUALIZED NEOEPITOPE CANCER VACCINE, INDUCES POSITIVE CLINICAL RESPONSES IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOURS | Maryland, November 2019
1947
portfolio_page-template-default,single,single-portfolio_page,postid-1947,bridge-core-1.0.4,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-18.2.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

VB10.NEO, AN INDIVIDUALIZED NEOEPITOPE CANCER VACCINE, INDUCES POSITIVE CLINICAL RESPONSES IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOURS